Shockwave Medical Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St set for higher open after retail earnings; Moderna soars
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
Shockwave Medical (SWAV) Misses Q1 EPS by 10c, Revenues Beat
May 12, 2020 4:20 PM EDTShockwave Medical (NASDAQ: SWAV) reported Q1 EPS of ($0.59), $0.10 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.17 million.
Recent Highlights
Recognized revenue of $15.2 million for the first quarter of 2020, representing an increase of 109% over the first quarter of 2019Completed enrollment in CAD III study of IVL for coronary use in the U.S.Completed enrollment in CAD IV pivotal study of IVL for coronary use in JapanExtended... More
